49 related articles for article (PubMed ID: 1820874)
1. Multiple dose pharmacokinetic study of cicletanine in healthy volunteers.
Peraire C; Torrent J; Pruñonosa J; Azcona O; Nomen M; Obach R
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():173-7. PubMed ID: 1820874
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic study of cicletanine in healthy volunteers.
Pruñonosa J; Peraire C; Torrent J; Obach R
Int J Clin Pharmacol Ther Toxicol; 1992 Aug; 30(8):265-70. PubMed ID: 1526688
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of cicletanine in patients with impaired renal function.
Jungers P
Drugs Exp Clin Res; 1988; 14(2-3):189-94. PubMed ID: 3416723
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics of cicletanine hydrochloride.
Fredj G
Drugs Exp Clin Res; 1988; 14(2-3):181-8. PubMed ID: 3416722
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
6. Urinary excretion of cicletanine in the rat. Stereochemical aspects.
Vistelle R; Lamiable D; Morin E; Trenque T; Kaltenbach M
Drug Metab Dispos; 1995 Sep; 23(9):988-92. PubMed ID: 8565790
[TBL] [Abstract][Full Text] [Related]
7. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
Fornasini G; Monti N; Brogin G; Gallina M; Eandi M; Persiani S; Bani M; Della Pepa C; Zara G; Strolin Benedetti M
Chirality; 1997; 9(3):297-302. PubMed ID: 9176996
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
O'Farrell AM; van Vliet A; Abou Farha K; Cherrington JM; Campbell DA; Li X; Hanway D; Li J; Guler HP
Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of adimolol after single and multiple dose administration in healthy volunteers.
Wiedemann I; Peil H; Justus H; Adamus S; Brantl V; Lohmann H
Arzneimittelforschung; 1985; 35(6):964-9. PubMed ID: 2862877
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics and pharmacokinetics of pinacidil after a single dose of a new slow release tablet in healthy volunteers.
Bareggi SR; Gambaro V; Valenti M; Benvenuti C
Arzneimittelforschung; 1998 Jul; 48(7):730-3. PubMed ID: 9706373
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of amiloride after inhalation and oral administration in adolescents and adults with cystic fibrosis.
Jones KM; Liao E; Hohneker K; Turpin S; Henry MM; Selinger K; Hsyu PH; Boucher RC; Knowles MR; Dukes GE
Pharmacotherapy; 1997; 17(2):263-70. PubMed ID: 9085317
[TBL] [Abstract][Full Text] [Related]
13. Levetiracetam pharmacokinetics in healthy dogs following oral administration of single and multiple doses.
Moore SA; Muñana KR; Papich MG; Nettifee-Osborne J
Am J Vet Res; 2010 Mar; 71(3):337-41. PubMed ID: 20187836
[TBL] [Abstract][Full Text] [Related]
14. Review of three studies to determine the efficacy and tolerance of cicletanine in the short- and long-term treatment of essential hypertension.
Fodor GP; Guinot P
Drugs Exp Clin Res; 1988; 14(2-3):195-204. PubMed ID: 3046883
[TBL] [Abstract][Full Text] [Related]
15. Study of the effects of cicletanine on the renin-angiotensin-aldosterone system.
Bippi H; Guinot P
Drugs Exp Clin Res; 1988; 14(2-3):215-20. PubMed ID: 3046885
[TBL] [Abstract][Full Text] [Related]
16. Safety and pharmacokinetics of NXN-188 after single and multiple doses in five phase I, randomized, double-blind, parallel studies in healthy adult volunteers.
Vaughan D; Speed J; Medve R; Andrews JS
Clin Ther; 2010 Jan; 32(1):146-60. PubMed ID: 20171420
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study of 2 dosages of a new antihypertensive agent, cicletanine, in elderly subjects].
Jungers P; Gavardin T; Salom M; Tarrade T; Berthet P
Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():125-9. PubMed ID: 2514651
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy male volunteers.
Mihara M; Ohnishi A; Tomono Y; Hasegawa J; Shimamura Y; Yamazaki K; Morishita N
Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):223-9. PubMed ID: 8314652
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive effect of non-diuretic doses of cicletanine on a stress-induced model in the rat.
Castro A; Florentino A; Fuentes JA
Drugs Exp Clin Res; 1988; 14(2-3):97-101. PubMed ID: 3416728
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic variability of nimodipine disposition after single and multiple oral dosing to hypertensive renal failure patients: parametric and nonparametric population analysis.
Terziivanov D; Atanasova I; Dimitrova V; Robeva R; Unger S; Mück W
Int J Clin Pharmacol Ther; 1999 Aug; 37(8):404-12. PubMed ID: 10475143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
